Journey Medical (DERM) Enterprise Value (2020 - 2026)
Journey Medical's (DERM) quarterly Enterprise Value came in at -$27.2 million in Q1 2026, down 29.18% YoY from -$38.4 million in Q1 2025, and down 12.94% on a QoQ basis from -$24.1 million in Q4 2025.
Journey Medical (DERM) Enterprise Value (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Enterprise Value data on file, last reported at -$27.2 million in Q1 2026.
- Quarterly Enterprise Value fell 29.18% year-over-year to -$27.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$27.2 million (down 29.18% YoY) and the FY2025 annual result came in at -$24.1 million, down 18.69% from the prior year.
- Enterprise Value slipped to -$27.2 million in Q1 2026, from -$24.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$17.0 million in Q2 2023 to a low of -$41.3 million in Q1 2022.
- A 5-year average of -$26.5 million and a median of -$24.7 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value tumbled 60.87% — and 2023, when it jumped 55.43%.
- Tracing DERM's Enterprise Value over 5 years: stood at -$32.0 million in 2022, then climbed by 14.25% to -$27.4 million in 2023, then advanced by 26.0% to -$20.3 million in 2024, then declined by 18.69% to -$24.1 million in 2025, then decreased by 12.94% to -$27.2 million in 2026.
- The last three Enterprise Value figures came in at -$27.2 million (Q1 2026), -$24.1 million (Q4 2025), and -$24.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Journey Medical | 205.38 Mn | 179.73 Mn | 12.37 Mn | -25.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.64 Mn |
| Mar 31, 2026 | -27.22 Mn |
| Dec 31, 2025 | -24.10 Mn |
| Sep 30, 2025 | -24.95 Mn |
| Jun 30, 2025 | -20.30 Mn |
| Mar 31, 2025 | -21.07 Mn |
| Dec 31, 2024 | -20.31 Mn |
| Sep 30, 2024 | -22.46 Mn |
| Jun 30, 2024 | -23.90 Mn |
| Mar 31, 2024 | -24.10 Mn |
| Dec 31, 2023 | -27.44 Mn |
| Sep 30, 2023 | -24.75 Mn |
| Jun 30, 2023 | -16.98 Mn |
| Mar 31, 2023 | -26.10 Mn |
| Dec 31, 2022 | -32.00 Mn |
| Sep 30, 2022 | -34.89 Mn |
| Jun 30, 2022 | -38.10 Mn |
| Mar 31, 2022 | -41.30 Mn |
| Dec 31, 2021 | -49.08 Mn |
| Sep 30, 2021 | -21.69 Mn |